Letters in Drug Design & Discovery

G. Perry
University of Texas
San Antonio, TX
Email: lddd@benthamscience.org


Fungal Metabolites as Potent Protein Kinase Inhibitors: Identification of a Novel Metabolite and Novel Activities of Known Metabolites

Author(s): Masayoshi Oyama, Zhihong Xu, Kuo-Hsiung Lee, Timothy D. Spitzer, Peter Kitrinos, Octerloney B. McDonald, Rosie R.J. Jones, Edward P. Garvey.


A novel undecylresorcinol dimer (1) was isolated from Coleophoma sp. and inhibited cFMS receptor tyrosine kinase (IC50 of 0.4 μM), with greater than 10-fold selectivity versus nine other protein kinases. The known fungal metabolites balanol and altenusin inhibited cFMS kinase and pp60c-Src kinase, respectively, even more potently and selectively. Altenusin inhibited pp60c-Src with an IC50 of 20 nM and a selectivity of at least 400-fold versus nine other protein kinases. Balanol inhibited cFMS receptor kinase with an IC50 of 1 nM and selectivities of 14-75-fold versus pp60c-Src and VEGF receptor kinases and greater than 10,000-fold versus seven other kinases.

Keywords: fungal metabolite, protein kinase inhibitor, cfms receptor tyrosine kinase, pp60c-src kinase, balanol, altenusin, alternariol

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

Year: 2004
Page: [24 - 29]
Pages: 6
DOI: 10.2174/1570180043485626